Allergic reactions

Allergic reactions are hypersensitive immune responses triggered by environmental antigens known as allergens, characterized primarily by Type I hypersensitivity (StatPearls, 2023). This biological process is initiated when specific Immunoglobulin E (IgE) antibodies, produced during an initial sensitization phase, bind to high-affinity Fc epsilon receptors on the surface of mast cells and basophils (NIH, 2022). Upon subsequent exposure, the allergen cross-links these surface-bound IgE molecules, triggering the rapid degranulation and release of potent inflammatory mediators such as histamine, leukotrienes, and prostaglandins (PubMed, 2021). These mediators act on target tissues to induce physiological changes including increased vascular permeability, smooth muscle contraction, and mucus hypersecretion, leading to clinical manifestations ranging from mild rhinitis to life-threatening systemic anaphylaxis (Wikipedia, 2024). Therapeutic strategies focus on mitigating this response by blocking histamine receptors, stabilizing mast cell membranes, or utilizing biologics like Omalizumab to neutralize circulating IgE before it can bind to immune cells (PubChem, 2023).

Other names

AllergyHypersensitivity reactionType I hypersensitivityAtopyAllergic response

Pharmacological management of allergic reactions involves several mechanisms: antagonism of Histamine H1 receptors to block mediator effects, sequestration of free IgE to prevent mast cell sensitization, inhibition of leukotriene receptors to reduce airway inflammation, and the use of alpha/beta-adrenergic agonists to counteract systemic anaphylactic symptoms (NIH, 2023; PubChem, 2023).